Literature DB >> 24798737

Deficiency in perlecan/HSPG2 during bone development enhances osteogenesis and decreases quality of adult bone in mice.

Dylan A Lowe1, Nadia Lepori-Bui, Peter V Fomin, Laura G Sloofman, Xiaozhou Zhou, Mary C Farach-Carson, Liyun Wang, Catherine B Kirn-Safran.   

Abstract

Perlecan/HSPG2 (Pln) is a large heparan sulfate proteoglycan abundant in the extracellular matrix of cartilage and the lacunocanalicular space of adult bones. Although Pln function during cartilage development is critical, evidenced by deficiency disorders including Schwartz-Jampel Syndrome and dyssegmental dysplasia Silverman-Handmaker type, little is known about its function in development of bone shape and quality. The purpose of this study was to understand the contribution of Pln to bone geometric and mechanical properties. We used hypomorph mutant mice that secrete negligible amount of Pln into skeletal tissues and analyzed their adult bone properties using micro-computed tomography and three-point-bending tests. Bone shortening and widening in Pln mutants was observed and could be attributed to loss of growth plate organization and accelerated osteogenesis that was reflected by elevated cortical thickness at older ages. This effect was more pronounced in Pln mutant females, indicating a sex-specific effect of Pln deficiency on bone geometry. Additionally, mutant females, and to a lesser extent mutant males, increased their elastic modulus and bone mineral densities to counteract changes in bone shape, but at the expense of increased brittleness. In summary, Pln deficiency alters cartilage matrix patterning and, as we now show, coordinately influences bone formation and calcification.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24798737      PMCID: PMC4137566          DOI: 10.1007/s00223-014-9859-2

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  36 in total

1.  HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation.

Authors:  Stephanie A Miller; Anissa J Brown; Mary C Farach-Carson; Catherine B Kirn-Safran
Journal:  Differentiation       Date:  2003-08       Impact factor: 3.880

2.  Contribution of collagen and mineral to the elastic-plastic properties of bone.

Authors:  A H Burstein; J M Zika; K G Heiple; L Klein
Journal:  J Bone Joint Surg Am       Date:  1975-10       Impact factor: 5.284

3.  Extracellular matrix proteoglycans control the fate of bone marrow stromal cells.

Authors:  Yanming Bi; Christina H Stuelten; Tina Kilts; Sunil Wadhwa; Renato V Iozzo; Pamela G Robey; Xiao-Dong Chen; Marian F Young
Journal:  J Biol Chem       Date:  2005-06-17       Impact factor: 5.157

4.  Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel.

Authors:  A L Boskey; L Spevak; S B Doty; L Rosenberg
Journal:  Calcif Tissue Int       Date:  1997-10       Impact factor: 4.333

5.  A comparison of mechanical properties derived from multiple skeletal sites in mice.

Authors:  Jennifer L Schriefer; Alexander G Robling; Stuart J Warden; Adam J Fournier; James J Mason; Charles H Turner
Journal:  J Biomech       Date:  2005-03       Impact factor: 2.712

6.  Expression of heparan sulfate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation.

Authors:  S E Smith; M M French; J Julian; B C Paria; S K Dey; D D Carson
Journal:  Dev Biol       Date:  1997-04-01       Impact factor: 3.582

7.  Genetic variation in bone growth patterns defines adult mouse bone fragility.

Authors:  Christopher Price; Brad C Herman; Thomas Lufkin; Haviva M Goldman; Karl J Jepsen
Journal:  J Bone Miner Res       Date:  2005-07-11       Impact factor: 6.741

8.  Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals.

Authors:  Kristine M Wiren; Xiao-Wei Zhang; Amber R Toombs; Viera Kasparcova; Michael A Gentile; Shun-ichi Harada; Karl J Jepsen
Journal:  Endocrinology       Date:  2004-05-06       Impact factor: 4.736

9.  Mechanisms of proteoglycan inhibition of hydroxyapatite growth.

Authors:  C C Chen; A L Boskey
Journal:  Calcif Tissue Int       Date:  1985-07       Impact factor: 4.333

10.  Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro.

Authors:  M M French; S E Smith; K Akanbi; T Sanford; J Hecht; M C Farach-Carson; D D Carson
Journal:  J Cell Biol       Date:  1999-05-31       Impact factor: 10.539

View more
  13 in total

Review 1.  The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.

Authors:  Stephen Douglass; Atul Goyal; Renato V Iozzo
Journal:  Connect Tissue Res       Date:  2015-07-16       Impact factor: 3.417

Review 2.  Extracellular matrix and developing growth plate.

Authors:  Johanna Myllyharju
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

3.  Knockdown of the pericellular matrix molecule perlecan lowers in situ cell and matrix stiffness in developing cartilage.

Authors:  Xin Xu; Zhiyu Li; Yue Leng; Corey P Neu; Sarah Calve
Journal:  Dev Biol       Date:  2016-08-27       Impact factor: 3.582

4.  Perlecan/Hspg2 deficiency impairs bone's calcium signaling and associated transcriptome in response to mechanical loading.

Authors:  Shaopeng Pei; Sucharitha Parthasarathy; Ashutosh Parajuli; Jerahme Martinez; Mengxi Lv; Sida Jiang; Danielle Wu; Shuo Wei; X Lucas Lu; Mary C Farach-Carson; Catherine B Kirn-Safran; Liyun Wang
Journal:  Bone       Date:  2019-11-09       Impact factor: 4.398

5.  Exome sequencing identified rare variants in genes HSPG2 and ATP2B4 in a family segregating developmental dysplasia of the hip.

Authors:  Sulman Basit; Alia M Albalawi; Essa Alharby; Khalid I Khoshhal
Journal:  BMC Med Genet       Date:  2017-03-21       Impact factor: 2.103

6.  Trabecular Bone Deficit and Enhanced Anabolic Response to Re-Ambulation after Disuse in Perlecan-Deficient Skeleton.

Authors:  Ashutosh Parajuli; Shaopeng Pei; Hongbo Zhao; Jerahme R Martinez; X Lucas Lu; X Sherry Liu; Mary C Farach-Carson; Catherine B Kirn-Safran; Liyun Wang
Journal:  Biomolecules       Date:  2020-01-29

7.  Knockdown of hspg2 is associated with abnormal mandibular joint formation and neural crest cell dysfunction in zebrafish.

Authors:  Barbara S Castellanos; Nayeli G Reyes-Nava; Anita M Quintana
Journal:  BMC Dev Biol       Date:  2021-03-08       Impact factor: 1.978

8.  New therapeutic targets in rare genetic skeletal diseases.

Authors:  Michael D Briggs; Peter A Bell; Michael J Wright; Katarzyna A Pirog
Journal:  Expert Opin Orphan Drugs       Date:  2015-09-24       Impact factor: 0.694

Review 9.  Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.

Authors:  Christiane S Hampe; Julie B Eisengart; Troy C Lund; Paul J Orchard; Monika Swietlicka; Jacob Wesley; R Scott McIvor
Journal:  Cells       Date:  2020-08-05       Impact factor: 6.600

Review 10.  Modular Proteoglycan Perlecan/HSPG2: Mutations, Phenotypes, and Functions.

Authors:  Jerahme R Martinez; Akash Dhawan; Mary C Farach-Carson
Journal:  Genes (Basel)       Date:  2018-11-16       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.